Publications by authors named "Jean P Hubble"

Claim this Profile
P
Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.
Peter A LeWitt, Danna Jennings, Kelly E Lyons, Rajesh Pahwa, Adrian L Rabinowicz, Jean P Hubble

Mov Disord· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term evaluation of deep brain stimulation of the thalamus.
Rajesh Pahwa, Kelly E Lyons, Steven B Wilkinson, Richard K Simpson, William G Ondo, Jean P Hubble

J Neurosurg· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
Yi-Ju Li, Sofia A Oliveira, Puting Xu, Eden R Martin, Judith E Stenger, Jean P Hubble

Hum Mol Genet· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Robert A Hauser, Jean P Hubble, Daniel D Truong,

Neurology· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
Sofia A Oliveira, William K Scott, Martha A Nance, Ray L Watts, Jean P Hubble

Arch Neurol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists.
Thomas Roth, David B Rye, Leona D Borchert, Cindy Bartlett, Donald L Bliwise, Jean P Hubble

Sleep Med· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
Sofia A Oliveira, William K Scott, Eden R Martin, Martha A Nance, Ray L Watts, Jean P Hubble

Ann Neurol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
Joelle M van der Walt, Kristin K Nicodemus, Eden R Martin, William K Scott, Martha A Nance, Jean P Hubble

Am J Hum Genet· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.
Anita L DeStefano, Mark F Lew, Lawrence I Golbe, Margery H Mark, Alice M Lazzarini, Jean P Hubble

Am J Hum Genet· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age at onset in two common neurodegenerative diseases is genetically controlled.
Yi-Ju Li, William K Scott, Dale J Hedges, Fengyu Zhang, P Craig Gaskell, Jean P Hubble

Am J Hum Genet· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term studies of dopamine agonists.
Jean P Hubble

Neurology· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease.
Robert A Hauser, William C Koller, Jean P Hubble, Teresita Malapira, Karen Busenbark

Mov Disord· May 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis